BiochemProbe — Life Science Research Reagents

Runcaciguat free base · Synonyms: BAY 1101042

Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined…

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

Runcaciguat structure

CAS No.: 1402936-61-1

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 400.00 BP-01884-50mg In stock Get quote
100 mg USD 620.00 BP-01884-100mg In stock Get quote
250 mg USD 1,020.00 BP-01884-250mg In stock Get quote
500 mg USD 1,520.00 BP-01884-500mg In stock Get quote
1 g USD 2,450.00 BP-01884-1g In stock Get quote
2 g Inquire BP-01884-2g Inquire Inquire

Need another size or custom synthesis? Request a quote.

Description

Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists.

Biological activity

In Vitro Runcaciguat (100 pM-10 μM; 10 min) activates wild-type soluble guanylate cyclase (sGC, EC50=789 nM) in HEK293 cells, but inactive against the β1H105A/F mutant, confirming that its activation is dependent on the histidine 105 residue of the β1 subunit. In Vivo Runcaciguat (1-10 mg/kg; oral gavage or mixed feed; 1-2 times a day; 2-12 weeks) significantly reduces proteinuria, improves renal function markers (such as Cyst-C, KIM-1), alleviates renal pathological damage (such as glomerular sclerosis, tubular degeneration) in chronic kidney disease (CKD) models such as ANG-SD rats, RenTG rats, ZDF rats and ZSF1 rats, and improves the survival rate of RenTG rats.

Identifiers

SMILES
O=C(NC1=CC([C@H](C2CC2)CC(O)=O)=CC=C1Cl)[C@@](C3=CC=C(Cl)C=C3)([H])[C@@H](C)C(F)(F)F
InChIKey
NCRMKIWHFXSBGZ-CNBXIYLPSA-N

Specifications

MW (average)
488.3270
Formula
C23H22Cl2F3NO3
CAS No.
1402936-61-1
Physical state
Solid
Color
White to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO 125 mg/mL

References

[1]. Wittrien T, et al. Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation. Biochem Pharmacol. 2025 Feb;232:116739.
[2]. Bénardeau A, et al. Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease. Naunyn Schmiedebergs Arch Pharmacol. 2021 Dec;394(12):2363-2379.
[3]. Kraehling JR, et al. The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats. Int J Mol Sci. 2023 Aug 25;24(17):13226.
[4]. Duh EJ, et al. Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator (sGCa) Runcaciguat in Diabetes and Ischemic Retinopathy. Diabetes. 2025 Apr 18:db240739.

Same research area

Search Cardiovascular Disease